ularitide
Jump to navigation
Jump to search
Contraindications
- of no benefit in acute heart failure
Dosage
Mechanism of action
Clinical trials
[1]
- decreases mean systolic blood pressure & serum pro-BNP
- no decrease in mortality[1]
More general terms
References
- ↑ 1.0 1.1 1.2 Packer M, O'Connor C, McMurray JJV et al. Effect of ularitide on cardiovascular mortality in acute heart failure. N Engl J Med 2017 May 18; 376:1956-1964. PMID: https://www.ncbi.nlm.nih.gov/pubmed/28402745
Hauptman PJ. Disease modification in acute decompensated heart failure. N Engl J Med. 2017 May 18;376(20):1987-1988. PMID: https://www.ncbi.nlm.nih.gov/pubmed/28402754